BACKGROUND Although angiotensin-converting enzyme (ACE) inhibitor therapy has been shown to improve clinical outcomes of patients with systolic dysfunction, it has been underused or prescribed in inadequate dosages by physicians in the treatment of congestive heart failure. Our goal was to evaluate whether integration of a clinical guideline within a continuous quality improvement program would...

objective(s): in this study, the effects of crocin against subchronic toxicity of diazinon (dzn) on systolic blood pressure (sbp) and heart rate (hr) were evaluated in rats. materials and methods: rats were equally divided into 7 groups; control (corn oil), dzn (15 mg/kg), crocin (each group received 12.5, 25 or 50 mg/kg crocin plus dzn), vitamin e (200 iu/kg plus dzn) and crocin (50 mg/kg) tre...

In the early 1990s, the idea first arose that plasma concentrations of B type natriuretic peptide (BNP) might help target scarce cardiac investigations towards the most deserving. This mainly referred to the possibility that BNP could detect which patients had heart failure and which did not. This was based on the fact that echocardiography slots were limited, and that heart failure was hard to...

1024x768 normal 0 false false false en-us x-none fa background : heart failure is a common health problem with poor prognosis. the gold standard for diagnosis is echocardiography but it is not always reachable, especially in emergency conditions. nt-pro-brain natriuretic peptide (nt-probnp) is a novel indicator for the diagnosis of heart failure and is being used in routine tests in emergency r...